Spaceflight-Associated Neuro-Ocular Syndrome

Types
Causes and contributors
Symptoms
Diagnostic tests
Non-pharmacological treatments
Drug treatments
Dietary molecular supplements
Regenerative or stem-cell drugs
Surgeries
Prevention strategies
When to see the flight surgeon/doctor
What to eat and what to avoid
FAQs

Spaceflight-Associated Neuro-Ocular Syndrome, or SANS, is a set of eye and optic nerve changes that can develop during long space missions. In simple terms, the body’s fluids shift toward the head in weightlessness. This shift can change the pressure and shape of delicate tissues in and around the eyes. When this happens for weeks or months, some astronauts develop swelling of the optic disc (the spot where the optic nerve enters the eye), flattening of the back of the eyeball, ripples in the layers under the retina, and a shift toward farsighted vision. These changes can alter how clearly a person sees, especially at near, and they can leave subtle imaging or vision test changes even after coming back to Earth. Scientists agree the condition is real and important, but the exact cause is still being worked out, and more than one mechanism is probably involved. PubMedNaturePMCNASA Technical Reports Server

SANS used to be called VIIP (Visual Impairment/Intracranial Pressure) because it looked a bit like the “pseudotumor cerebri” picture on Earth. Over time, researchers found that the space version is not identical to typical high-pressure brain disorders, so the name shifted to SANS. The best current view is that microgravity causes head-to-head fluid shifts, mild or uneven pressure effects in the compartments around the optic nerve, and changes in the way cerebrospinal fluid and blood drain from the head. These effects may be worsened by cabin carbon dioxide, salt and fluid balance, and individual biology. NaturePMCEyeWiki

Types

Below are the core types or features doctors talk about when they describe SANS. Each type is described in simple language so the picture is clear.

Optic disc edema (optic nerve head swelling)
The edge of the optic nerve looks puffy on eye exam and imaging. The swelling is often mild to moderate and can be uneven between the two eyes. This swelling can develop in flight and slowly settle after return. In SANS, the swelling is not always tied to a large, sustained rise in brain pressure like on Earth, which is why scientists think local fluid flow around the optic nerve sheath may matter. PubMedNature
Posterior globe flattening
The very back wall of the eye looks less curved, as if it were gently pressed from behind. This small shape change can make vision shift toward farsightedness (hyperopia), especially for near work. Imaging shows the flattening most clearly, and in some astronauts a degree of flattening can linger after landing. PubMedPMC
Choroidal folds and retinal striae
The thin layers under the retina can form fine ripples or ridges. People may notice mild distortion of straight lines or textures, or they may notice nothing if folds are small. These folds are a visible sign that mechanical forces are acting on the back of the eye. PubMed
Cotton-wool spots and RNFL thickening
Small white patches called cotton-wool spots can appear in the nerve fiber layer of the retina. Optical coherence tomography (OCT) can also show thickening of that layer. These signs point to stress in local microcirculation and axons. PubMed
Refractive shift toward hyperopia
After long missions, some astronauts need slightly weaker reading glasses or notice that near vision is worse. This shift matches the small change in eye shape described above. It usually improves, but not always completely right away. PubMed
Optic nerve sheath changes
Imaging can show a slightly wider optic nerve sheath or changes in the cerebrospinal fluid space around the optic nerve. This supports the idea of fluid compartment changes rather than a simple, uniform rise of pressure in the whole head. PMC
Asymmetry and persistence
The findings can be uneven between eyes, and some imaging changes can persist for months after landing, even when symptoms improve. PMC

Causes and contributors

SANS is likely multifactorial. That means many small pushes act together rather than one single cause. Each item below is a plausible mechanism or risk factor supported by astronaut data, ground analog studies, or expert reviews. Where the science is still developing, that is noted.

Headward (cephalad) fluid shift in microgravity
Weightlessness allows blood and other fluids to move from the legs and abdomen up into the chest, neck, and head. This shift can change venous pressure, tissue pressure, and cerebrospinal fluid dynamics around the eyes. This is the central, best-supported driver. NaturePMC
Mild or compartmentalized cerebrospinal fluid (CSF) pressure effects
Rather than a big whole-brain pressure rise, SANS may reflect uneven CSF pooling around the optic nerve sheaths. Local pressure on the back of the eye and nerve could explain swelling and globe flattening without the classic high-pressure picture. PMC
Venous congestion and reduced head/neck drainage
If veins in the head and orbit do not drain as well in microgravity, pressure can build in small vascular beds and around the optic nerve, nudging tissues to swell. Nature
Elevated cabin carbon dioxide (CO₂)
The International Space Station often runs at higher CO₂ than Earth air. CO₂ can dilate blood vessels and affect acid–base balance, which may worsen head vascular congestion and symptoms like headache. It is considered a possible amplifier, not a sole cause. EyeWiki
Altered glymphatic and interstitial fluid clearance
Microgravity may change how fluids move through and around the brain and eyes. Reduced “wash-out” could allow slow build-up of fluid near the optic nerve. This is a leading, still-evolving hypothesis. PMCSpringerLink
One-carbon metabolism status (folate/B-vitamins) and genetics
Variants in genes that govern folate-related metabolism and higher homocysteine have been associated with optic disc edema during head-down tilt (a spaceflight analog) and with SANS risk signals in astronaut cohorts. This points to nutrition-genetics interactions that may change tissue resilience to fluid/pressure stress. PMCNASA Technical Reports Server
Salt and fluid balance
High sodium intake and altered fluid regulation in flight may increase tissue and vascular volume in the head, adding to the load on ocular tissues. This is considered a modifiable factor under study. NASA Technical Reports Server
Body posture analogs (head-down tilt)
On Earth, strict head-down tilt bed rest reproduces headward fluid shifts and can trigger SANS-like changes, validating the fluid-shift mechanism and allowing safe countermeasure testing. PubMed
Valsalva-type straining during exercise or tasks
Resistive exercise and task-related breath-holding can transiently raise intrathoracic and venous pressures, potentially adding brief extra stress to ocular venous and CSF compartments. (This remains a contributor rather than a primary cause.) Nature
Individual vascular anatomy
Natural variation in venous sinuses, jugular valves, and optic nerve sheath compliance may make some people more prone to the same fluid shift. PMC
Radiation exposure in space
Space radiation can affect vascular and connective tissues over time. It is being explored as a co-factor that might change tissue responses or healing after microgravity stress. NASA Technical Reports Server
Reduced circadian cues and sleep disruption
Disrupted sleep and circadian rhythms can alter autonomic tone, CO₂ handling, and fluid regulation, which may subtly push the system toward congestion. NASA Technical Reports Server
Deconditioning and muscle pump loss
Less leg muscle activity reduces the natural “pump” that helps return blood from the lower body on Earth, making the headward shift more persistent aloft. Nature
Changes in ocular perfusion pressure
Small shifts in blood pressure and intraocular pressure can reduce the driving pressure that feeds the retina and optic nerve, interacting with local swelling. Nature
Connective tissue remodeling over months
Sustained mechanical stress can cause slow remodeling in sclera and choroid, explaining why globe flattening and folds can persist after landing in some cases. PMC
Microvascular autoregulation limits
If the eye’s tiny blood vessels cannot fully adapt to the new pressure balance, they may allow leakage or ischemic spots (like cotton-wool spots). PubMed
CO₂-exercise interaction
Exercise in a higher-CO₂ cabin could briefly magnify head vascular congestion compared with exercise at Earth-normal CO₂, though data are still limited. EyeWiki
Hormonal and fluid regulation changes
Spaceflight alters renin-angiotensin-aldosterone, antidiuretic hormone, and other regulators that fine-tune volume and osmotic balance, which can shift head/eye fluid status. NASA Technical Reports Server
Suit/helmet environment during EVAs (possible)
Periods with different pressure, CO₂, and work of breathing inside suits may transiently stress head and eye fluids; this is being evaluated. NASA Technical Reports Server
Duration in space
Risk and magnitude are higher with long-duration missions compared with short trips, suggesting a dose-time relationship. PubMed

Symptoms

Not everyone with SANS has symptoms. Some people have only imaging changes. When symptoms happen, they are usually mild to moderate and often related to near vision.

Blurred near vision that was not present before flight, often noticed while reading checklists or screens. PubMed
Needing less plus at near or noticing a shift toward farsightedness on refraction. PubMed
Headache, sometimes linked to higher CO₂ or long work days, with unclear direct relation to eye swelling. EyeWiki
Eyestrain or fatigue with sustained near work. Nature
Slight distortion of straight lines if choroidal folds are prominent. PubMed
Reduced contrast sensitivity making faint details a bit harder to see. Nature
Subtle color vision changes on testing, even when color looks normal in daily life. Nature
Mild depth-perception changes because one eye may be a little different from the other. Nature
Occasional visual field spots or small blind-area changes on perimetry. Nature
Glare sensitivity or discomfort with bright lights. Nature
Slow focusing when switching from far to near or near to far. Nature
A sense of eye pressure without true pain. PMC
Dull ache around the brow after heavy visual tasks. Nature
No symptoms at all despite clear changes on OCT or photos (this is common). PubMed
Symptoms that improve after landing, though some imaging signs may linger. PMC

Diagnostic tests

SANS testing combines simple bedside checks, formal vision tests, laboratory/biologic markers under study, electrodiagnostic tools, and imaging. Below are 20 tests grouped into five easy-to-understand categories (4 in each group). Together they build a complete picture.

A) Physical exam

Visual acuity for distance and near
This is the basic “read the chart” test. In SANS the near line often drops a little compared with pre-flight. Tracking these numbers over time helps detect small changes early. PubMed
Pupil exam (look for a relative afferent pupillary defect)
Shining a light in each eye checks if the optic nerve is carrying signals equally. A subtle defect can hint at optic nerve stress when imaging looks borderline. Nature
Confrontation visual fields
A quick bedside screen for field defects. While not as sensitive as automated perimetry, it can flag obvious changes in real time. Nature
Intraocular pressure (IOP) by tonometry
IOP itself is usually normal in SANS, but tracking it helps rule out other causes of optic disc swelling or vision change. Nature

B) Manual/bedside vision tests

Refraction and retinoscopy
Measuring the exact glasses prescription shows the hyperopic shift linked to posterior globe flattening. Comparing to pre-flight numbers is key. PubMed
Amsler grid
A simple square grid helps people notice wavy or distorted lines, a sign that choroidal folds may be affecting how the retina lays. PubMed
Near-point of accommodation and convergence
These quick checks look at how well the eyes focus and team at close range, which can feel different when near vision has changed. Nature
Color vision plates (Ishihara or D-15)
Standardized color tests pick up subtle loss that might not be noticed day-to-day but matters for precision tasks. Nature

C) Lab and pathological tests

Folate, vitamin B12, vitamin B6, riboflavin, and related markers
These nutrients run the one-carbon metabolism pathway. Low status or imbalance can raise homocysteine and has been tied to optic disc edema risk in analog studies. In astronauts, nutrient status and certain gene variants are being studied as risk modifiers. PMCNASA Technical Reports Server
Plasma homocysteine
Higher homocysteine is a biologic signal that one-carbon metabolism is strained, and it shows associations with disc edema risk in ground analogs. PMC
Genetic testing for selected one-carbon pathway SNPs
Variants in genes such as MTRR, SHMT1 and others have been explored for links to SANS-like edema in analogs, suggesting some people may be more susceptible. (This is a research tool, not routine screening for the public.) PMCNASA Technical Reports Server
Basic electrolytes and osmolality
Sodium and fluid balance matter to volume shifts. These labs provide context for how the body handles fluid and salt during missions. NASA Technical Reports Server

D) Electrodiagnostic and objective functional tests

Automated perimetry (visual field testing)
Computer-driven field maps find small blind-spot changes that go beyond bedside screening and can track recovery trends after landing. Nature
Visual evoked potentials (VEP)
Small electrodes record the brain’s response to visual patterns. Delays can signal optic pathway stress even when acuity is decent. Nature
Electroretinography (ERG; pattern or multifocal)
ERG measures the retina’s electrical response. In SANS, ERG helps confirm that the retina is functioning, and that the issue is more with mechanics/optic nerve than with photoreceptors. Nature
Chromatic pupillometry / objective pupillography
Light-induced pupil responses give a quantitative look at optic nerve and retinal ganglion pathways, adding confidence when findings are subtle. Nature

E) Imaging tests

Optical coherence tomography (OCT)
OCT provides micrometer-level cross-sections of the retina and optic nerve head. It shows nerve fiber layer thickening, posterior globe flattening signatures, and choroidal folds. This is the workhorse imaging test for SANS. ScienceDirectPubMed
Color fundus photography / ultra-widefield imaging
High-resolution photos document cotton-wool spots, disc margins, and folds over time. Side-by-side comparisons make slow trends visible. ScienceDirect
Orbital and brain MRI
MRI can show posterior globe flattening, optic nerve sheath prominence, and CSF spaces around the nerve. It helps separate SANS from other causes of disc edema. PubMedScienceDirect
Orbital ultrasound (including optic nerve sheath diameter)
Ultrasound offers a portable look at the posterior eye wall and optic nerve sheath. In space or analogs, it supports quick checks when MRI is not available. ScienceDirect

Non-pharmacological treatments

The goal is to reverse headward fluid shifts, optimize environment/nutrition, and catch changes early.

Lower-body negative pressure (LBNP): a sealed chamber around the lower body gently “sucks” blood/fluids toward the legs, countering headward shift; research shows reduced jugular vein area/pressure and favorable ICP trends at feasible low pressures. Operational use requires short sessions and monitoring. humanresearchroadmap.nasa.gov
Veno-constrictive thigh cuffs (VTC/“Braslet”): elastic cuffs sequester venous blood in the thighs and can reduce cranial/conduit venous dimensions; durations and pressures are being refined for efficacy and comfort. humanresearchroadmap.nasa.gov
Inspiratory resistance breathing (Impedance Threshold Device, ITD): brief breathing against resistance transiently lowers intrathoracic pressure, increases venous return to the heart, and reduces jugular vein area; promising as a short, simple countermeasure. humanresearchroadmap.nasa.gov
Artificial gravity (short-arm centrifugation): intermittent or continuous centrifugation creates a “pseudo-gravity” gradient. Short daily sessions tested in bed-rest analogs altered peripapillary thickness but did not clearly prevent folds/ODE at the tested dose; protocols are being optimized. humanresearchroadmap.nasa.gov
“Swim-goggle” IOP modulation (experimental): carefully raising IOP a little may oppose any ICP rise at the optic nerve; must be limited/monitored to avoid glaucoma risk. humanresearchroadmap.nasa.gov
Compression garments (waist-to-thigh) to help keep volume in the legs during certain tasks; used operationally in other programs, under study for SANS. humanresearchroadmap.nasa.gov
Exercise scheduling with venous management (e.g., using VTC/LBNP around workouts) to blunt exercise-related head/neck engorgement. NASA Technical Reports Server
Environmental CO₂ control: keeping cabin CO₂ in the lower nominal range reduces one potential stressor on cerebral blood flow—even though SANS can occur without CO₂ elevation. humanresearchroadmap.nasa.gov
Sleep strategy + evening fluid management: timing fluids and using pre-sleep LBNP to minimize nocturnal headward shift (being evaluated operationally). humanresearchroadmap.nasa.gov
Personalized optics on-orbit: adjustable readers or swappable lenses to correct hyperopic shift and reduce eyestrain—treats symptoms while other countermeasures address mechanisms. humanresearchroadmap.nasa.gov
Routine in-flight OCT/fundus imaging with rapid review to detect early change and trigger countermeasures. humanresearchroadmap.nasa.gov
Task rotation and visual-rest breaks to reduce continuous near-focus load. PMC
Neck/jaw harness ergonomics to avoid jugular compression from straps or postures. humanresearchroadmap.nasa.gov
Nutritional optimization of one-carbon pathway (adequate folate, B12, choline) under flight dietitian guidance; see supplements section below. NASA Technical Reports Server
Hydration targeting (avoid over-hydration before long near-work blocks; maintain euhydration overall). humanresearchroadmap.nasa.gov
Habitability design features (future vehicles: integrated LBNP “sleep stations”, easy-don VTC). humanresearchroadmap.nasa.gov
Pre-flight bed-rest screening with and without CO₂ to identify higher-risk responders and test personal countermeasure “recipes.” Physiology Journals
Circadian alignment (light therapy/sleep hygiene) to stabilize autonomic/vascular tone. PMC
On-orbit ultrasound of neck veins to tailor VTC/LBNP settings in real-time. humanresearchroadmap.nasa.gov
Mission planning (spacing of high-risk tasks, duration management for very long missions) while countermeasures are still maturing. humanresearchroadmap.nasa.gov

Drug treatments

Important safety note: There is no approved, standard drug therapy for SANS. Any medication use for astronauts is specialist-supervised and often based on idiopathic intracranial hypertension (IIH) evidence on Earth, not on SANS itself. Doses below are reference ranges from IIH literature and are not medical advice for spaceflight.

Acetazolamide (carbonic anhydrase inhibitor)
Purpose: lower CSF production and ICP; may also lower IOP. Mechanism: inhibits carbonic anhydrase in choroid plexus → less CSF. Typical IIH dosing: starts ~500 mg twice daily, titratable up to 4 g/day in divided doses as tolerated; flight surgeons would individualize. Time: hours to days for effect; weeks for optic disc changes. Key side effects: paresthesias, fatigue, dysgeusia, GI upset, kidney stones; can lower IOP (affecting trans-laminar pressure). SANS note: a single case post-flight used 500 mg/day for 6 weeks then 250 mg/day for 2 weeks; effect was limited and creatinine rose, so it was stopped—not a current routine SANS countermeasure. Medscapehumanresearchroadmap.nasa.gov
Topiramate (antiepileptic with weak CAI activity)
Purpose: alternate ICP-lowering and headache control in IIH. Mechanism: reduces CSF production; promotes weight loss on Earth. Typical IIH dosing: start 25 mg daily, titrate to 50–100 mg twice daily as tolerated. Side effects: cognitive slowing, paresthesias, kidney stones, mood changes. SANS: no direct trials; sometimes considered if a medication is needed and acetazolamide is not tolerated. Practical NeurologyBPS Publications
Furosemide (loop diuretic; adjunct in IIH)
Purpose: adjunct to reduce CSF via choroid plexus ion transport effects and diuresis. Typical IIH dosing: 20–40 mg/day, often with potassium supplementation. Side effects: electrolyte loss, dehydration. SANS: not studied; not a standard SANS therapy. American Academy of Orthopaedic Surgeons
GLP-1 receptor agonist (Exenatide)
Purpose: experimental ICP-lowering; human IIH phase 2 trial lowered ICP at 2.5 h, 24 h, and 12 weeks. Mechanism: GLP-1 receptors in choroid plexus reduce CSF secretion. Typical research dosing in IIH: subcutaneous exenatide (e.g., Byetta; protocols vary; some studies used 20 µg injections in trials). Side effects: nausea, GI upset; rare pancreatitis concerns. SANS: theoretical; no SANS trials—mentioned as a potential future avenue. PMCISRCTN
Short-course corticosteroid (e.g., dexamethasone/prednisone)
Purpose: reduce papilledema rapidly when vision is threatened (IIH rescue). Mechanism: complex; may transiently lower ICP but risks rebound on taper. IIH practice: not for long-term use due to adverse effects and rebound ICP; reserved for special situations. Side effects: fluid retention, mood, glucose changes; rebound risk. SANS: not recommended as routine. MedscapeWebEye
Mannitol (osmotic) / hypertonic saline
Purpose: temporary ICP reduction in emergencies on Earth. Mechanism: osmotic gradient draws water out of brain/CSF space. Use: hospital only; short-term. SANS: not practical or studied for in-flight routine care. (Context from ICP care, not SANS-specific.) Medscape
Combination therapy (acetazolamide + topiramate)
Purpose: leverage different mechanisms in IIH when monotherapy insufficient. SANS: unstudied; any use would be individualized by flight surgeons. MDPI
CAI eye drops (e.g., brinzolamide)
Purpose: lower IOP (not ICP). SANS caution: IOP is usually normal; changing it could worsen the pressure difference at the optic nerve if ICP is altered. Use is not established for SANS. humanresearchroadmap.nasa.gov
Cardiac glycosides (experimental, IIH literature mentions)
Purpose/mechanism: inhibit Na⁺/K⁺-ATPase in choroid plexus; theoretical CSF reduction. Status: not standard outside research. Medscape
Headache-directed analgesics
Purpose: symptom control only (no effect on ocular structure). Choice and timing: per medical direction to avoid confounding physiologic monitoring. SANS: supportive, not disease-modifying. (General neuro-ophthalmic practice.) ResearchGate

Dietary molecular supplements

No supplement has proven SANS prevention. The strongest nutrition link so far is the one-carbon pathway (folate/B12/choline), where adequate status and certain genetic variants relate to risk signals in analogs. Doses below reflect typical adult daily targets used on Earth; space diets are individualized by flight dietitians.

Folate (vitamin B9) — ~400 µg DFE/day. Function: donor of one-carbon units for DNA/methylation; supports endothelial health. Mechanism: normalizes one-carbon metabolism linked to SANS signals. NASA Technical Reports Server
Vitamin B12 — ~2.4 µg/day. Function: cofactor in homocysteine → methionine; low B12 raises homocysteine. Mechanism: healthier one-carbon flux. NASA Technical Reports Server
Vitamin B6 — ~1.3–1.7 mg/day. Function: homocysteine trans-sulfuration. Mechanism: supports lower homocysteine. NASA Technical Reports Server
Riboflavin (B2) — ~1.1–1.3 mg/day. Function: MTHFR cofactor in one-carbon metabolism. Mechanism: supports methylation balance. NASA Technical Reports Server
Choline — ~425–550 mg/day. Function: methyl donor; membrane phospholipids. Mechanism: complements folate/B12 pathways. NASA Technical Reports Server
Omega-3 fatty acids (EPA/DHA) — ~250–500 mg/day combined. Function: endothelial and neural membrane support. Mechanism: vascular tone/inflammation modulation (general). (General nutrition; SANS-specific data lacking.)
Lutein + Zeaxanthin — ~10 mg + 2 mg/day (AREDS2-style). Function: macular pigment support. Mechanism: antioxidant/retinal support (symptom resilience).
Vitamin D — per mission protocol. Function: bone, immune, neural health. Mechanism: broad physiologic support during long missions.
Magnesium — ~300–420 mg/day. Function: vascular tone/nerve conduction. Mechanism: supports autonomic stability (general).
Nitrate-rich foods (beetroot/greens) — dietary, not pill. Function: NO pathway support. Mechanism: may aid vascular regulation; evidence in SANS is indirect.

Again: these are supportive nutrition targets, not treatments. Flight dietitians personalize intakes; over-supplementation can be harmful.

Regenerative or stem-cell drugs

At present, there are no approved “immunity booster,” regenerative, or stem-cell drugs for SANS. The condition is mechanical/fluid-distribution-driven, not a loss of retinal neurons from inflammation or degeneration. For clarity:

Stem-cell therapies — not indicated; no trials for SANS.
Growth factors/neuroprotectives — no clinical evidence for SANS.
Immunomodulators/“boosters” — SANS is not an immune deficiency; such drugs are not appropriate.
Gene therapy — no target identified for SANS.
Regenerative biologics — no role established.
Experimental biologics — not justified outside well-designed trials.

The most promising avenues today remain mechanical countermeasures, environmental management, and nutritional adequacy. humanresearchroadmap.nasa.gov

Surgeries

Surgery is not part of routine SANS care. In the unlikely case that a crew member developed vision-threatening intracranial hypertension–like disease post-flight that failed medical measures, teams might consider procedures commonly used in IIH:

Optic nerve sheath fenestration (ONSF) — small window in the sheath to relieve pressure and protect vision if papilledema is progressive. Risks include diplopia/optic nerve injury. (IIH practice.) PMC
CSF shunting (lumboperitoneal or ventriculoperitoneal shunt) — diverts CSF to reduce ICP when medical therapy fails. Shunts can need revisions. (IIH practice.) PMC
Telemetry-guided pressure management (post-flight) — not a “surgery” for SANS per se, but sometimes paired with shunts in IIH programs. PMC
Emergency osmotherapy in hospital (mannitol/hypertonic saline) — bridging, not long-term treatment. (ICP care.) Medscape
Refractive correction (glasses/contacts) — non-surgical but included here to emphasize symptom relief rather than tissue intervention.

Prevention strategies

Routine in-flight OCT/MCI imaging to catch early changes. humanresearchroadmap.nasa.gov
Personalized countermeasure mix (LBNP + VTC + ITD) with data-driven scheduling. humanresearchroadmap.nasa.gov+1
CO₂ kept low within habitat nominal range. humanresearchroadmap.nasa.gov
Evening LBNP sessions and fluid-timing before sleep. humanresearchroadmap.nasa.gov
Optimize one-carbon nutrition (folate, B12, choline) and monitor homocysteine. NASA Technical Reports Server
Adjustable near-vision optics onboard to reduce strain. humanresearchroadmap.nasa.gov
Exercise + venous management pairing (e.g., cuffs around workouts). NASA Technical Reports Server
Ergonomic harnessing to avoid neck vein compression. humanresearchroadmap.nasa.gov
Pre-flight analog screening (HDT bed rest ± CO₂) to identify responders. Physiology Journals
Plan for Mars/Lunar mission specifics (longer durations, partial-g, more robust on-board countermeasures). humanresearchroadmap.nasa.gov

When to see the flight surgeon/doctor

Any new near-vision blur, headache with visual symptoms, or “dim spots.”
Rapid change in reading performance or need for stronger readers.
Eye pain, red eye, or sudden vision loss (not typical for SANS—urgent).
After landing, if headaches, vision changes, or visual field symptoms persist beyond the first weeks of recovery.

What to eat and what to avoid

What to eat (supportive, not curative):

Leafy greens, legumes, fortified grains (folate). NASA Technical Reports Server
Eggs, fish, dairy or fortified foods (B12, choline). NASA Technical Reports Server
Fish/seafood a few times weekly (EPA/DHA).
Citrus, berries, colorful vegetables (antioxidants; lutein/zeaxanthin from spinach/kale).
Nuts, seeds, whole grains (magnesium, B-vitamins).

What to limit/avoid:

Excess sodium and ultra-processed salty items (fluid retention). humanresearchroadmap.nasa.gov
Large fluid boluses right before long near-work or sleep (timing matters). humanresearchroadmap.nasa.gov
Supplements beyond mission protocols (over-supplementation can backfire). NASA Technical Reports Server
Irregular meal timing that worsens sleep/circadian rhythm. PMC
Anything that compresses the neck veins during/after eating (e.g., too-tight collars).

FAQs

1) Is SANS the same as idiopathic intracranial hypertension (IIH)?
No. They share some features (like optic disc edema), but SANS happens in microgravity with a headward fluid shift, and IOP is usually normal. IIH occurs on Earth with elevated ICP and different demographics. humanresearchroadmap.nasa.gov

2) How common is SANS?
On long missions, ~70% show at least one imaging sign, but only ~15% develop mild, clinically graded disc edema. Many have no symptoms and recover. humanresearchroadmap.nasa.gov

3) What’s the main symptom?
Blurry near vision from a small hyperopic shift. EyeWiki

4) Is it dangerous?
So far, no permanent vision loss has been documented from SANS. But for exploration missions, preventing visual risks is a priority. humanresearchroadmap.nasa.gov

5) Does high CO₂ cause SANS?
CO₂ can influence brain blood flow, but SANS can develop without elevated CO₂. It is not required. humanresearchroadmap.nasa.gov

6) What countermeasures work best now?
Approaches that reverse headward fluid shifts—LBNP, VTC, ITD breathing—are most promising; protocols are being optimized for feasibility and dose. humanresearchroadmap.nasa.gov+1

7) Does artificial gravity fix it?
Short daily centrifugation in analogs did not clearly prevent folds/ODE at tested doses; more research is ongoing on duration/intensity. humanresearchroadmap.nasa.gov

8) Are there medicines for SANS?
There’s no standard SANS drug. Some IIH medicines (like acetazolamide) lower ICP on Earth, but routine use for SANS is not established; one post-flight case had limited benefit. humanresearchroadmap.nasa.gov

9) What about new drugs?
The GLP-1 agonist exenatide lowered ICP in an IIH trial; whether that helps SANS is unknown yet. PMC

10) Do vitamins help?
Adequate folate/B12/choline status may relate to lower risk in some individuals; this is an active research area and part of nutrition planning—not a cure. NASA Technical Reports Server

11) Can we predict who will get SANS?
Risk seems higher with crowded optic discs and certain one-carbon SNPs; pre-flight analog testing helps identify responders. PMCNASA Technical Reports Server

12) Is SANS permanent?
Changes usually improve after landing; ongoing follow-up monitors any long-term effects. humanresearchroadmap.nasa.gov

13) Does exercise help or hurt?
Exercise is essential for fitness; pairing it with venous management can reduce transient head/neck engorgement. NASA Technical Reports Server

14) Are glasses enough?
Glasses relieve symptoms (blur) but don’t treat the mechanism. They are part of an overall plan. humanresearchroadmap.nasa.gov

15) What’s next for Mars missions?
Integrating daily, low-burden countermeasures (LBNP/VTC/ITD), nutrition tuning, CO₂ control, and smart monitoring is the roadmap under study now. humanresearchroadmap.nasa.gov

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.